Stocks · Health care · Surgical & Medical Instruments & Apparatus

Orchestra BioMed Holdings, Inc.

OBIO Clue Score66
United States Fiscal year ends December CIK 0001814114
$5.95 +3.84% Close, 9 Oct 2026
Price $5.95 −39.66% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 4 Aug 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2021Operating income−0.4Net income−0.4EPS, diluted−0.02Fiscal year 2022Revenue3.5Operating income−32.7Net income−33.6EPS, diluted−2.24Fiscal year 2023Revenue2.8 −21.9%Operating income−51.5Net income−49.1EPS, diluted−1.48Fiscal year 2024Revenue2.6 −4.4%Operating income−64.3Net income−61.0EPS, diluted−1.66Fiscal year 2025Revenue33.5 +1,169.2%Operating income−51.8Net income−52.7EPS, diluted−1.11
FY2021FY2022FY2023FY2024FY2025
Revenue n/a 3.5 2.8 2.6 33.5
Growth −21.9% −4.4% +1,169.2%
Operating income −0.4 −32.7 −51.5 −64.3 −51.8
Net income −0.4 −33.6 −49.1 −61.0 −52.7
Growth
EPS, diluted −0.02 −2.24 −1.48 −1.66 −1.11

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2021Fiscal year 2022Operating margin−924.3%Net margin−951.3%Free cash flow margin−845.7%Fiscal year 2023Operating margin−1,866.2%Net margin−1,779.7%Free cash flow margin−1,674.1%Fiscal year 2024Operating margin−2,437.5%Net margin−2,313.3%Free cash flow margin−1,927.5%Fiscal year 2025Operating margin−154.7%Net margin−157.4%Free cash flow margin−147.7%
FY2021FY2022FY2023FY2024FY2025
Operating margin n/a −924.3% −1,866.2% −2,437.5% −154.7%
Net margin n/a −951.3% −1,779.7% −2,313.3% −157.4%
Free cash flow margin n/a −845.7% −1,674.1% −1,927.5% −147.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2021Operating cash flow−0.3Fiscal year 2022Operating cash flow−29.3Capital expenditure−0.6Free cash flow−29.9Fiscal year 2023Operating cash flow−46.1Capital expenditure−0.1Free cash flow−46.2Fiscal year 2024Operating cash flow−50.6Capital expenditure−0.3Free cash flow−50.8Fiscal year 2025Operating cash flow−49.0Capital expenditure−0.5Free cash flow−49.5
FY2021FY2022FY2023FY2024FY2025
Operating cash flow −0.3 −29.3 −46.1 −50.6 −49.0
Capital expenditure n/a −0.6 −0.1 −0.3 −0.5
Free cash flow n/a −29.9 −46.2 −50.8 −49.5
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2021Cash1.8Shareholders’ equity−3.9Fiscal year 2022Cash19.8Shareholders’ equity−6.9Fiscal year 2023Cash30.6Shareholders’ equity68.0Fiscal year 2024Cash22.3Total debt15.0Net cash (debt)7.3Shareholders’ equity33.0Debt to equity0.46Fiscal year 2025Cash34.7Total debt15.0Net cash (debt)19.7Shareholders’ equity53.6Debt to equity0.28
FY2021FY2022FY2023FY2024FY2025
Cash 1.8 19.8 30.6 22.3 34.7
Total debt n/a n/a n/a 15.0 15.0
Net cash (debt) n/a n/a n/a 7.3 19.7
Shareholders’ equity −3.9 −6.9 68.0 33.0 53.6
Debt to equity n/a n/a n/a 0.46 0.28

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
n/a −924.3% −1,866.2% −2,437.5% −154.7%
n/a −951.3% −1,779.7% −2,313.3% −157.4%
n/a −845.7% −1,674.1% −1,927.5% −147.7%
Spending
n/a 621.1% 1,225.4% 1,622.6% 173.8%
n/a 397.2% 734.0% 907.2% 80.4%
n/a 16.7% 2.8% 11.0% 1.5%
Returns
n/a n/a −72.2% −185.2% −98.4%
−0.2% −35.2% −51.6% −80.1% −45.9%
Balance and payout
n/a n/a n/a 0.46 0.28
3.6% 45.0% 28.5% 56.7% 44.8%